Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUR.L Regulatory News (SUR)

  • There is currently no data for SUR

Director Dealing

25 Nov 2019 17:15

RNS Number : 5993U
Sureserve Group PLC
25 November 2019
 

Sureserve Group plc

("Sureserve" or the "Group")

Director Dealing

 

Sureserve was notified today that on 22 November 2019, Harwood Capital LLP purchased 324,711 ordinary shares in Sureserve ("Ordinary Shares") at a price of 29 pence per Ordinary Share.

 

Christopher Mills, Non-Executive Director of Sureserve, is deemed to be person discharging managerial responsibilities at Harwood Capital LLP and is therefore deemed to have an interest in 30,489,711 Ordinary Shares of Sureserve representing 19.18% of the issued share capital of Sureserve.

 

 

Enquiries

Sureserve

Financial Public Relations

Bob Holt, Chairman, 07778 798816

Camarco

Peter Smith, Chief Financial Officer

Ginny Pulbrook

Telephone: 020 3961 5210

 

Tom Huddart

Telephone: 020 3757 4992

 

Shore Capital

Antonio Bossi

Mark Brown

Telephone: 020 7408 4050

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Harwood Capital LLP as investment manager to itself and two other companies

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills, non-exec director of the issuer and director and shareholder of the other entities

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Sureserve Group plc

b)

 

LEI

 

 

213800FHUTNVX8LWPH50

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.10 each

Identification code

GB00BSKS1M86

 

b)

 

Nature of the transaction

 

 

Share purchase

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.29

324,711

d)

 

Aggregated information

- Aggregated volume

324,711

- Price

£94,166.19

e)

 

Date of the transaction

 

 

22 November 2019

f)

 

Place of the transaction

 

 

London Stock Exchange

 

Notes to editors

Sureserve is a leading compliance and energy support services group that performs critical functions in homes, public and commercial buildings, with a focus on clients in the UK public sector and regulated markets. Services are delivered through two divisions: Compliance and Energy Services.

The Group was founded in 1988 and is headquartered in Basildon. It currently employs some 2,000 staff from 23 offices across the UK.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDELFLKFFFFBZ
Date   Source Headline
26th Apr 20231:59 pmRNSForm 8.3 – Sureserve Group plc – Christine Jones
26th Apr 202310:40 amRNSForm 8.3 - Sureserve Group Plc
26th Apr 20238:03 amGNWForm 8.5 (EPT/RI) - Sureserve Group Plc
25th Apr 20233:48 pmRNSForm 8.3 - Sureserve
25th Apr 20231:00 pmRNSForm 8.3 - Sureserve Group Plc
25th Apr 202311:53 amRNSForm 8.3 - Sureserve Group plc
25th Apr 202310:30 amRNSForm 8.3 - Sureserve Group Plc
25th Apr 20239:04 amRNSForm 8.3 - Sureserve Group PLC
25th Apr 20238:38 amGNWForm 8.5 (EPT/RI) - Sureserve Group Plc
24th Apr 20233:12 pmGNWForm 8.3 - Sureserve Group plc
24th Apr 20231:59 pmRNSForm 8.3 - [offeree/offeror]
24th Apr 20231:57 pmRNSForm 8.3 - Sureserve Group PLC
24th Apr 20231:28 pmRNSForm 8.3 - Sureserve Group plc
24th Apr 202311:45 amEQSForm 8.3 - Maitland Institutional Services Limited: Re Sureserve Group PLC
24th Apr 202311:19 amRNSForm 8.3 - Sureserve Group Plc
24th Apr 202311:17 amRNSForm 8.3 - Sureserve Group plc
24th Apr 202310:24 amGNWForm 8.5 (EPT/RI) - Sureserve Group Plc
24th Apr 20239:33 amGNWForm 8.3 - [SURESERVE GROUP PLC - Opening Declaration - 21 04 2023] - (CGAML)
21st Apr 20232:22 pmRNSForm 8.3 - Sureserve Group Plc
21st Apr 20239:24 amRNSForm 8.3 - Sureserve Group plc
21st Apr 20237:00 amRNSRecommended Cash Acquisition
21st Mar 20231:47 pmRNSResult of AGM
21st Feb 20237:00 amRNSHolding(s) in Company
20th Feb 20234:31 pmRNSHolding(s) in Company
16th Feb 20237:05 amRNSAnnual Report and Accounts and Notice of GM
24th Jan 20237:00 amRNSFinal Results
16th Jan 20233:36 pmRNSTotal Voting Rights
3rd Jan 20239:08 amRNSExercise of Options and Total Voting Rights
15th Dec 202211:52 amRNSShare issue
13th Dec 20229:07 amRNSGrant of Options
16th Nov 202212:02 pmRNSExercise of Options and Total Voting Rights
13th Oct 202211:59 amRNSExercise of Options and Total Voting Rights
11th Oct 20227:00 amRNSPost Year-End Trading Update
5th Oct 20227:00 amRNS£5.4m Contract & Completion with the DIO and MoD
21st Sep 20223:52 pmRNSTotal Voting Rights
9th Aug 20225:15 pmRNSExercise of Options and Total Voting Rights
3rd Aug 20227:00 amRNSExercise of Options and Total Voting Rights
1st Jul 20224:02 pmRNSHolding(s) in Company
20th Jun 20229:13 amRNSExercise of Options and Total Voting Rights
16th Jun 20229:09 amRNSTotal Voting Rights
6th Jun 20229:11 amRNSDirector/PDMR Shareholding
26th May 20222:08 pmRNSDirector/PDMR Shareholding
18th May 202211:48 amRNSTransaction by Director / PDMR
17th May 20227:00 amRNSInterim Results
11th May 20228:05 amRNSExercise of Options and Total Voting Rights
9th May 20227:00 amRNS8 Year Contract Extension worth £68m with L&Q
5th May 20227:00 amRNSAppointment of Non-Executive Director
3rd May 20227:00 amRNSNotice of Investor Presentation
14th Apr 20227:00 amRNSNotice of Interim Results
13th Apr 20227:00 amRNSAppointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.